Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic
agents
    7.
    发明授权
    Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents 失效
    取代的6H-7,8-二氢硫杂(3,2-D) - 嘧啶作为血糖水平

    公开(公告)号:US4871739A

    公开(公告)日:1989-10-03

    申请号:US5720

    申请日:1987-01-21

    CPC分类号: C07D495/04

    摘要: There are disclosed certain 2-substituted-4-substituted 6H-7,8-dihydrothiapyrano[3,2-d]pyrimidines which have oral hypoglycemic activity and with such ability to lower blood sugar are useful in the treatment of type II diabetes and/or obesity with associated insulin resistance. Processes for the preparation of such compounds and compositions containing such compounds as the active ingredient thereof are also disclosed. The compounds are also .beta.-adrenergic blocking agonists or .alpha.-adrenergic blocking agents and act as ocular antihypertensives and are useful for the treatment of glaucoma and other eye disorders.

    摘要翻译: 公开了具有口服降血糖活性并具有降低血糖的能力的某些2-取代-4-取代的6H-7,8-二氢硫吡喃并[3,2-d]嘧啶可用于治疗II型糖尿病和/ 或具有相关胰岛素抵抗的肥胖。 还公开了制备这些化合物和含有这些化合物作为其活性成分的组合物的方法。 该化合物也是β-肾上腺素能阻断激动剂或α-肾上腺素能阻断剂,并且作为眼部抗高血压药物,并且可用于治疗青光眼和其它眼睛疾病。

    N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoalkyl)
glycyl amino acid antihypertensive agents
    8.
    发明授权
    N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoalkyl) glycyl amino acid antihypertensive agents 失效
    N-羧甲基取代的赖氨酰和α-(ε-氨基烷基)甘氨酰氨基酸抗高血压药

    公开(公告)号:US4602002A

    公开(公告)日:1986-07-22

    申请号:US463412

    申请日:1983-02-07

    CPC分类号: C07K5/0222 A61K38/00

    摘要: Compounds of the formula: ##STR1## wherein R.sup.2 is --(CH.sub.2).sub.k --X--(CH.sub.2).sub.j --NHR.sup.3 ; wherein k is 0 to 3, j is 1 or 2; X is F or OH; and, R.sup.3 is hydrogen; loweralkyl or loweraralkyl which may be substituted by hydroxy, carboxy, carbamoyl, or carbalkoxy; or, acyl; and, a pharmaceutically acceptable salt thereof; are inhibitors of angiotensin I converting enzyme useful as antihypertensive agents.

    摘要翻译: 下式的化合物:其中R 2是 - (CH 2)k -X-(CH 2)j -NHR 3; 其中k为0至3,j为1或2; X是F或OH; R3为氢; 可被羟基,羧基,氨基甲酰基或烷氧基取代的低级烷基或低级烷基; 或酰基; 及其药学上可接受的盐; 是用作抗高血压药的血管紧张素I转化酶的抑制剂。

    N.sup.2 -(Substituted)carboxymethyl-N.sup.6 -(substituted)-lysyl-and
.alpha..epsilon.-aminoalkyl)glycyl amino acid antihypertensive agents
    9.
    发明授权
    N.sup.2 -(Substituted)carboxymethyl-N.sup.6 -(substituted)-lysyl-and .alpha..epsilon.-aminoalkyl)glycyl amino acid antihypertensive agents 失效
    N 2 - (取代的)羧甲基-N 6 - (取代的) - 赖氨酰 - 和α-(ε-氨基烷基)甘氨酰氨基酸抗高血压药

    公开(公告)号:US4555503A

    公开(公告)日:1985-11-26

    申请号:US466622

    申请日:1983-02-18

    IPC分类号: A61K38/00 C07K5/02 A61K37/00

    摘要: Compounds of the formula: ##STR1## wherein R.sup.2 is ##STR2## wherein k is 2 to 5; R.sup.3 is hydrogen; loweralkyl and substituted loweralkyl where the substituents are carboxy, hydroxy, and amino; or aralkyl, substituted aralkyl, heteroaralkyl, and substituted heteroaralkyl where the aryl and heteroaryl substituents are carboxy, hydroxy, and amino; and C is COOR; CONH.sub.2 ; or CH.sub.2 OH; and a pharmaceutically acceptable salt thereof; are inhibitors of angiotensin I converting enzyme useful as antihypertensive agents.

    摘要翻译: 下式的化合物:其中R 2为,其中k为2至5; R3是氢; 低级烷基和取代的低级烷基,其中取代基是羧基,羟基和氨基; 或芳烷基,取代的芳烷基,杂芳烷基和取代的杂芳烷基,其中芳基和杂芳基取代基是羧基,羟基和氨基; C为COOR; CONH2; 或CH 2 OH; 及其药学上可接受的盐; 是用作抗高血压药的血管紧张素I转化酶的抑制剂。